1. Home
  2. AXR vs MSLE Comparison

AXR vs MSLE Comparison

Compare AXR & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMREP Corporation

AXR

AMREP Corporation

N/A

Current Price

$22.51

Market Cap

132.0M

Sector

Real Estate

ML Signal

N/A

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$9.61

Market Cap

154.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AXR
MSLE
Founded
1961
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Homebuilding
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
132.0M
154.6M
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
AXR
MSLE
Price
$22.51
$9.61
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
12.0K
44.8K
Earning Date
03-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.91
N/A
Revenue
$12,831,000.00
N/A
Revenue This Year
$10.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$5.44
52 Week High
$29.01
$13.39

Technical Indicators

Market Signals
Indicator
AXR
MSLE
Relative Strength Index (RSI) 40.02 58.10
Support Level $21.92 $9.10
Resistance Level $23.52 $10.57
Average True Range (ATR) 0.80 0.51
MACD -0.02 -0.09
Stochastic Oscillator 47.36 48.88

Price Performance

Historical Comparison
AXR
MSLE

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: